Aprilafton AB

Active
556700-1044Limited company (AB)Registered 2006DJURSHOLM

Key figures

800 901 kr+3,5%
Revenue 2024/25
−0,0%
Average annual change 2021/22–2024/25
0250 k500 k750 k1 m2021/222022/232023/242024/25

Key figures

2024/25

Summary: Aprilafton AB

What kind of company is it?

Aprilafton AB (org. no. 556700-1044) is a limited company (AB). The company was registered in 2006 and has existed for 20 years. Registered seat: Djursholm. Industry according to Statistics Sweden: other general medical practice activities (SNI 86212).

How is the company doing financially?

Net sales in financial year 2025 were 800 901 kr, up 3,5 % on the previous year (774 000 kr). Net profit for 2025 was 2 427 182 kr (303 % of net sales). The company was profitable in all 4 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 800 901 kr. At the end of financial year 2025, total assets were 12 100 022 kr and equity 11 824 312 kr (equity ratio 97,7 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2023/24

Proposed dividend 125 000 kr.

Summary of annual reports2022–2025
2021/222022/232023/242024/25
Sales revenue801 000801 000774 000800 901
Profit for the reporting year1 744 7202 197 6881 770 9902 427 182
Retained earnings of previous periods————
Total assets7 305 4668 969 99910 749 16712 100 022
Total liabilities282 764138 859227 037275 710
Total equity7 022 7028 831 14010 522 13011 824 312
Employees1111
Proposed dividend——125 000—

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.